Ohio Innovation Fund
VC Fund
Columbus, United States
Ohio Innovation Fund is a VC fund in Columbus focused on Health Care and Software. We partner with bold, visionary founders & disruptive companies to create industries of the future.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 32%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Ohio Innovation Fund invests in
Stages Ohio Innovation Fund invests in
Countries Ohio Innovation Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 9 (22%)
- Software 8 (20%)
- Medical 6 (15%)
- Medical Device 6 (15%)
- Biotechnology 3 (7%)
Stage
- Series A 12 (29%)
- Series B 9 (22%)
- Series C 5 (12%)
- Funding Round 5 (12%)
- Seed 4 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bill Baumel
Managing Director
|
Managing Director | Total investments: 26 | Find email | |
Faith Voinovich
Principal
|
Principal | Total investments: 0 | Find email | |
Michael Hughes
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
Michael Triplett
Venture Advisor
|
Venture Advisor | Total investments: 17 | Find email | |
Michael Triplett
Venture Advisor
|
Venture Advisor | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Niobium Microsystems
|
Niobium Microsystems creates custom integrated circuit and microelectronic system solutions for clients with complex power, performance, and security constraints. | $23M / Seed / Dec 03, 2025 | |
Mojo Vision
|
Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today'smobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree.Mojo Vision was founded in 2015 and headquartered in Saratoga, California. | $75M / Series B / Sep 04, 2025 | |
|
Niobium Microsystems
|
Niobium Microsystems creates custom integrated circuit and microelectronic system solutions for clients with complex power, performance, and security constraints. | $5.5M / Seed / May 07, 2024 | |
Trace
|
Trace is the Canva for AR. The simplest way ever to make AR recordings and experiences for brands, retail, training and more. Partners include teams at Qualcomm, Deutsche Telekom, Lenovo, Telefonica and other fortune 500 companies. Contact us to work together or learn more. Info@Trace3d.app | $2M / Pre-Seed / Apr 24, 2024 | |
Clarametyx Biosciences
|
Clarametyx Biosciences is a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms. | $33M / Series A / Jan 05, 2024 | |
Lentechs
|
Lentechs is a medical device company that develops a novel soft bifocal contact lens. The company is headquartered in Columbus, Ohio. | $6M / Venture - Series Unknown / Oct 24, 2023 | |
AKRU
|
AKRU’s commercial real estate investment platform uses blockchain technology to create a secure and easy-to-use marketplace. AKRU offers investors the opportunity for fractionalized ownership for as low as $1,000 in the form of security tokens. The platform’s technology enables instantaneous transactions to be recorded on an immutable ledger,building investor trust. Tokenization shortens the transaction cycle and is able to compress the closing and settlement period of assets to mere seconds – making the world’s largest investment class more accessible and liquid for investors. Since launching the paid beta in October 2020, AKRU has secured 14 assets and over 50 investors for the marketplace. AKRU relaunched its platform in March of 2021 as the Title Sponsor for the Security Token Summit. Akru has been mentioned in major publications like Coin Telegraph, Investor.com, securities.io & Business Journals. | $2M / Seed / Nov 22, 2022 | |
Genetesis
|
Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened. | $17.5M / Series C / Oct 06, 2022 | |
Enable Injections
|
Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform, a body-worn technology that enables subcutaneous administration of large-volume pharmaceutical and biologic therapies without traditional intravenous methods. The company focuses on engineering devices that allow patients to receive treatmentthrough simple, hands-free injections under the skin while collaborating with pharmaceutical partners to integrate its delivery systems with specific therapies. Its services encompass design, clinical support, manufacturing, and supply of combination products built around the enFuse technology. Enable Injections engages in partnerships to expand application of its delivery systems across varied therapeutic areas and supports regulatory and commercialization planning with its collaborators. | $215M / Series C / Jan 27, 2022 | |
Aware
|
Aware is a cloud intelligence platform that adopts the latest advancements in cognitive computing, artificial intelligence, and behavioral analytics to amplify enterprise value by monitoring the social graph. They harness the power of their platform’s insights into human behavior and interactivity to create great value for the enterprise. | $60M / Series C / Oct 13, 2021 | |
| See all 41 investments → | |||
Co-Investors
JumpStart Inc.
10 deals together
Rev1 Ventures
10 deals together
Draper Triangle
7 deals together
JobsOhio
7 deals together
CincyTech
6 deals together
North Coast Ventures
5 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Ohio Innovation Fund invest in?
Ohio Innovation Fund invests primarily in Health Care, Software and Medical startups, most often at Series A and Series B stage. Most of the 41 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ohio Innovation Fund?
Public channels for Ohio Innovation Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ohio Innovation Fund?
The team at Ohio Innovation Fund includes Bill Baumel (Managing Director), Faith Voinovich (Principal) and Michael Hughes (Venture Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
